{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:35:27Z","timestamp":1777926927088,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,18]],"date-time":"2018-11-18T00:00:00Z","timestamp":1542499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["156701"],"award-info":[{"award-number":["156701"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["518232\/291117"],"award-info":[{"award-number":["518232\/291117"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004960","name":"Universidad Aut\u00f3noma del Estado de M\u00e9xico","doi-asserted-by":"publisher","award":["3326\/2012C"],"award-info":[{"award-number":["3326\/2012C"]}],"id":[{"id":"10.13039\/501100004960","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.11.041","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T21:14:07Z","timestamp":1543266847000},"page":"248-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice"],"prefix":"10.1016","volume":"37","author":[{"given":"Wael","family":"Hegazy-Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Zepeda-Escobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laucel","family":"Ochoa-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M. Eloy","family":"Contreras-Ort\u00edz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esvieta","family":"Tenorio-Borroto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Barbabosa-Pliego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Esteban","family":"Aparicio-Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5441-0863","authenticated-orcid":false,"given":"Rigoberto","family":"Oros-Pantoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Rivas-Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"D\u00edaz-Albiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha Jain","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"V\u00e1zquez-Chagoy\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.11.041_b0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2018.11.041_b0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas disease: a Latin American health problem becoming a world health problem","volume":"115","author":"Schmunis","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2018.11.041_b0015","unstructured":"Special Programme for Research and Training in Tropical Diseases. Tropical disease research\u202f: progress 1991-92\u202f: eleventh programme report of the UNDP\/WORLD BANK\/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Geneva: World Health Organization; 1993."},{"key":"10.1016\/j.vaccine.2018.11.041_b0020","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.vaccine.2006.05.008","article-title":"The antipoverty vaccines","volume":"24","author":"Hotez","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.041_b0025","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1128\/IAI.72.11.6245-6254.2004","article-title":"Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening","volume":"72","author":"Bhatia","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.041_b0030","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1586\/erv.09.45","article-title":"Vaccination approaches against Trypanosoma cruzi infection","volume":"8","author":"Cazorla","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.11.041_b0035","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1586\/14760584.4.6.867","article-title":"Current status and future prospects for a vaccine against American trypanosomiasis","volume":"4","author":"Garg","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.11.041_b0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-3024.1999.00201.x","article-title":"Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein","volume":"21","author":"L\u00facia Pereira-Chioccola","year":"1999","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.11.041_b0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-3024.2000.00260.x","article-title":"Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase","volume":"22","author":"Ribeirao","year":"2000","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.11.041_b0050","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CVI.00144-08","article-title":"Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice","volume":"15","author":"Bhatia","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.11.041_b0055","doi-asserted-by":"crossref","first-page":"e1050","DOI":"10.1371\/journal.pntd.0001050","article-title":"Testing the efficacy of a multi-component DNA-prime\/DNA-boost vaccine against Trypanosoma cruzi infection in dogs","volume":"5","author":"Aparicio-Burgos","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.11.041_b0060","doi-asserted-by":"crossref","DOI":"10.5772\/18021","article-title":"Non-viral delivery systems in gene therapy and vaccine development","author":"Bolhassani","year":"2011","journal-title":"Non-Viral Gene Ther InTech"},{"key":"10.1016\/j.vaccine.2018.11.041_b0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/elsc.200420068","article-title":"Electric field-induced cell membrane permeabilization and gene transfer: theory and experiments","volume":"5","author":"Faurie","year":"2005","journal-title":"Eng Life Sci"},{"key":"10.1016\/j.vaccine.2018.11.041_b0070","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/erv.09.76","article-title":"Therapeutic HPV DNA vaccines","volume":"8","author":"Monie","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.11.041_b0075","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.vaccine.2018.11.041_b0080","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1016\/j.vaccine.2009.07.005","article-title":"Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery","volume":"27","author":"Best","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.041_b0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.imlet.2012.10.003","article-title":"Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model","volume":"148","author":"Daemi","year":"2012","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2018.11.041_b0090","first-page":"1","article-title":"Oficial Mexicana, Especificaciones t\u00e9cnicas para la producci\u00f3n, cuidado y uso de los animales de laboratorio","author":"Norma","year":"1999","journal-title":"Nom-062-Zoo"},{"key":"10.1016\/j.vaccine.2018.11.041_b0095","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1128\/IAI.69.6.3916-3923.2001","article-title":"LYT1 protein is required for efficient in vitro infection by Trypanosoma cruzi","volume":"69","author":"Manning-Cela","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.041_b0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/hgtb.2011.209","article-title":"Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device","volume":"23","author":"Lin","year":"2012","journal-title":"Hum Gene Ther Methods"},{"key":"10.1016\/j.vaccine.2018.11.041_b0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0976-500X.72350","article-title":"Blood sample collection in small laboratory animals","volume":"1","author":"Parasuraman","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.vaccine.2018.11.041_b0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pntd.0000797","article-title":"Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice","volume":"4","author":"Gupta","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.11.041_b0115","first-page":"389","article-title":"Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi","volume":"4","author":"Brener","year":"1962","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.vaccine.2018.11.041_b0120","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4269\/ajtmh.2009.81.390","article-title":"Trypanosoma cruzi circulating in the southern region of the state of Mexico (Zumpahuacan) are pathogenic: a dog model","volume":"81","author":"Barbabosa-Pliego","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2018.11.041_b0125","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/0300985813485099","article-title":"Principles for valid histopathologic scoring in research","volume":"50","author":"Gibson-Corley","year":"2013","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2018.11.041_b0130","series-title":"Principles and procedures of statistics: a biometrical approach","author":"Steel","year":"1997"},{"key":"10.1016\/j.vaccine.2018.11.041_b0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/icb.2010.109","article-title":"Plasmid DNA vaccination using skin electroporation promotes poly-functional CD4 T-cell responses","volume":"89","author":"Br\u00e5ve","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.11.041_b0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000156483","article-title":"Electroporation at low voltages enables DNA vaccine to provide protection against a lethal H5N1 avian influenza virus challenge in mice","volume":"51","author":"Zhou","year":"2008","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2018.11.041_b0145","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.4049\/jimmunol.164.9.4635","article-title":"Increased DNA vaccine delivery and immunogenicity by electroporation in vivo","volume":"164","author":"Widera","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.11.041_b0150","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4161\/hv.7.8.16274","article-title":"Transcutaneous and intradermal vaccination","volume":"7","author":"Combadiere","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2018.11.041_b0155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.vaccine.2007.10.041","article-title":"Intradermal\/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques","volume":"26","author":"Hirao","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.11.041_b0160","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-3024.1998.00154.x","article-title":"The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi","volume":"20","author":"Kumar","year":"1998","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.11.041_b0165","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1128\/IAI.70.10.5547-5555.2002","article-title":"Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection","volume":"70","author":"Garg","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.041_b0170","doi-asserted-by":"crossref","first-page":"e59434","DOI":"10.1371\/journal.pone.0059434","article-title":"TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.11.041_b0175","doi-asserted-by":"crossref","first-page":"e1004828","DOI":"10.1371\/journal.ppat.1004828","article-title":"A two-component DNA-prime\/protein-boost vaccination strategy for eliciting long-term, protective T cell immunity against Trypanosoma cruzi","volume":"11","author":"Gupta","year":"2015","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.vaccine.2018.11.041_b0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/icb.1989.50","article-title":"IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi","volume":"67","author":"Brodskyn","year":"1989","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.11.041_b0185","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1073\/pnas.91.20.9519","article-title":"Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses","volume":"91","author":"Raz","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2018.11.041_b0190","doi-asserted-by":"crossref","first-page":"079","DOI":"10.1385\/MB:19:1:079","article-title":"Dendritic cell delivery of plasmid DNA: applications for controlled genetic immunization","volume":"19","author":"Mumper","year":"2001","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.vaccine.2018.11.041_b0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2660(05)55002-8","article-title":"Human clinical trials of plasmid DNA vaccines","volume":"55","author":"Liu","year":"2005","journal-title":"Adv Genet"},{"key":"10.1016\/j.vaccine.2018.11.041_b0200","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/IAI.01163-07","article-title":"Oral vaccination with salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi","volume":"76","author":"Cazorla","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.041_b0205","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1128\/IAI.73.11.7356-7365.2005","article-title":"Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection","volume":"73","author":"Miyahira","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.041_b0210","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1128\/IAI.72.4.2350-2357.2004","article-title":"Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of chagas\u2019 disease","volume":"72","author":"Marinho","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.11.041_b0215","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1590\/S0001-37652001000400008","article-title":"The pathogenesis of Chagas\u2019 disease: when autoimmune and parasite-specific immune responses meet","volume":"73","author":"Soares","year":"2001","journal-title":"An Da Acad Bras Ci\u00eancias"},{"key":"10.1016\/j.vaccine.2018.11.041_b0220","doi-asserted-by":"crossref","first-page":"e0003625","DOI":"10.1371\/journal.pntd.0003625","article-title":"Immune protection against Trypanosoma cruzi Induced by TcVac4 in a canine model","volume":"9","author":"Aparicio-Burgos","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2018.11.041_b0225","series-title":"Mechanisms of disease: a textbook of comparative general pathology","author":"Slauson","year":"2002"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18315640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:29:46Z","timestamp":1759400986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18315640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18315640"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}